RAD Alignment with US FDA for Development of RAD101
Filed with ASX · · 3 pages · English
Radiopharm Theranostics Limited on 6ix
Earlier from Radiopharm Theranostics
- Quarterly Activities/Appendix 4C Cash Flow Report
- Notice of Annual General Meeting/Proxy Form
- Radiopharm receives $8M advance on FY26 R&D tax incentive
- Notification regarding unquoted securities - RAD
- Change of Director's Interest Notices x 4
Follow Radiopharm Theranostics into a list and get an email when it puts out news.
Follow Radiopharm Theranostics